Open AccessJournal Article
The effects of anterior pituitary adrenocorticotropic hormone in myasthenia gravis with tumor of the thymus.
Soffer Lj,Gabrilove Jl +1 more
Reads0
Chats0
About:
This article is published in Journal of the Mount Sinai Hospital, New York.The article was published on 1948-07-01 and is currently open access. It has received 5 citations till now. The article focuses on the topics: Somatotropic cell & Anterior pituitary.read more
Citations
More filters
Journal ArticleDOI
Effects of adrenocorticotrophic hormone on neuro-muscular function in patients with myasthenia gravis.
Clara Torda,Harold G. Wolff +1 more
TL;DR: Five patients moderately to severely ill with myasthenia gravis received 400 mg adrenocorticotrophic hormone given in amounts of 20 mg every 6 hours, and changes that may indicate the beginnings of an incomplete remission occurred after completion of the injections.
Journal Article
Corticotropin and cortisone in diseases of the nervous system.
TL;DR: The purpose of this article is to review critically the results reported to date and to compare corticotropin and cortisone as therapeutic agents in diseases of the nervous system in which the existing therapeutic agents are inadequate.
Journal ArticleDOI
Die Pathogenese der Myasthenia gravis als immunologisches Problem
TL;DR: Clinical evidence, especially the overlap of myasthenia gravis with other autoimmune diseases, and the demonstration of a autoantibody reactive with cross striations of skeletal muscle have led to discussion to discuss.
Journal ArticleDOI
Benefit from adrenocorticotrophin in myasthenia gravis
TL;DR: Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH) and the mean duration of benefit was approximately six months.